Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TECLISTAMAB-CQYV Cause Clostridium difficile colitis? 10 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Clostridium difficile colitis have been filed in association with TECLISTAMAB-CQYV. This represents 0.6% of all adverse event reports for TECLISTAMAB-CQYV.

10
Reports of Clostridium difficile colitis with TECLISTAMAB-CQYV
0.6%
of all TECLISTAMAB-CQYV reports
1
Deaths
7
Hospitalizations

How Dangerous Is Clostridium difficile colitis From TECLISTAMAB-CQYV?

Of the 10 reports, 1 (10.0%) resulted in death, 7 (70.0%) required hospitalization.

Is Clostridium difficile colitis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TECLISTAMAB-CQYV. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does TECLISTAMAB-CQYV Cause?

Cytokine release syndrome (406) Immune effector cell-associated neurotoxicity syndrome (153) Off label use (122) Death (116) Plasma cell myeloma (96) Infection (83) Neutropenia (74) Fatigue (72) Pyrexia (67) Covid-19 (64)

What Other Drugs Cause Clostridium difficile colitis?

CYCLOPHOSPHAMIDE (717) PREDNISONE (619) DEXAMETHASONE (575) METHOTREXATE (562) ETOPOSIDE (503) CYTARABINE (489) VINCRISTINE (482) LENALIDOMIDE (388) METHYLPREDNISOLONE (385) CIPROFLOXACIN (378)

Which TECLISTAMAB-CQYV Alternatives Have Lower Clostridium difficile colitis Risk?

TECLISTAMAB-CQYV vs TEDIZOLID TECLISTAMAB-CQYV vs TEDUGLUTIDE TECLISTAMAB-CQYV vs TEDUGLUTIDE\WATER TECLISTAMAB-CQYV vs TEGAFUR TECLISTAMAB-CQYV vs TEGAFUR\URACIL

Related Pages

TECLISTAMAB-CQYV Full Profile All Clostridium difficile colitis Reports All Drugs Causing Clostridium difficile colitis TECLISTAMAB-CQYV Demographics